1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. FATP
  4. FATP Inhibitor

FATP Inhibitor

FATP Inhibitors (3):

Cat. No. Product Name Effect Purity
  • HY-N0401A
    (Z)-Ligustilide
    Inhibitor 99.11%
    (Z)-Ligustilide is extracted from Ligusticum chuanxiong Hort, has antimicrobial and antifungal activity, exhibits an average antifungal score of 5.6. (Z)-Ligustilide is orally active, it inhibits the expression of FATP5 and DGAT, inhibits fatty acid uptake and esterification in mice and has potential as therapeutics for nonalcoholic fatty liver disease (NAFLD) . (Z)-Ligustilide is also able to reactivate ERα, has epigenetic regulation, and is used in the study of tamoxifen-resistant breast cancer.
  • HY-141699
    FATP1-IN-1
    Inhibitor 99.55%
    FATP1-IN-1 (compound 5k) is a fatty acid transport protein 1 (FATP1) inhibitor. FATP1-IN-1 is an inhibition of recombinant human or mouse acyl-CoA synthetase activity of FATP1, with the IC50 values of 0.046 μM or 0.60 μM, respectively.
  • HY-118634
    trans-Resveratrol-4'-O-D-Glucuronide
    Inhibitor
    Trans-Resveratrol-4'-O-D-Glucuronide (R-4G) is a metabolite of resveratrol with anti-fat accumulation property, and can be used for metabolic research.